Shandong Lukang Pharmaceutical Co.,Ltd. (SHA:600789)
China
· Delayed Price · Currency is CNY 8.92
-0.07 (-0.78%)
Mar 10, 2026, 2:14 PM CST
SHA:600789 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 9,396 | 8,582 | 6,361 | 6,418 | 6,593 | 8,248 | Upgrade
|
| Market Cap Growth | 1.81% | 34.92% | -0.89% | -2.66% | -20.06% | 29.96% | Upgrade
|
| Enterprise Value | 11,761 | 10,613 | 8,698 | 8,777 | 8,485 | 9,911 | Upgrade
|
| Last Close Price | 8.99 | 9.44 | 6.96 | 7.02 | 7.18 | 8.92 | Upgrade
|
| PE Ratio | 42.45 | 21.75 | 25.84 | 46.50 | 74.00 | 36.19 | Upgrade
|
| PS Ratio | 1.52 | 1.38 | 1.03 | 1.14 | 1.34 | 1.96 | Upgrade
|
| PB Ratio | 2.29 | 2.11 | 1.70 | 1.83 | 1.92 | 2.46 | Upgrade
|
| P/TBV Ratio | 2.96 | 2.72 | 2.20 | 2.33 | 2.43 | 2.93 | Upgrade
|
| P/FCF Ratio | - | 69.42 | 23.91 | 400.72 | - | - | Upgrade
|
| P/OCF Ratio | 30.90 | 21.31 | 10.53 | 14.44 | 37.15 | 35.16 | Upgrade
|
| EV/Sales Ratio | 1.90 | 1.70 | 1.42 | 1.56 | 1.72 | 2.36 | Upgrade
|
| EV/EBITDA Ratio | 15.77 | 14.83 | 13.44 | 16.19 | 18.82 | 27.92 | Upgrade
|
| EV/EBIT Ratio | 35.30 | 33.51 | 32.68 | 45.23 | 59.19 | 89.28 | Upgrade
|
| EV/FCF Ratio | -581.37 | 85.85 | 32.69 | 547.99 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.73 | 0.70 | 0.77 | 0.81 | 0.77 | 0.65 | Upgrade
|
| Debt / EBITDA Ratio | 4.03 | 3.97 | 4.44 | 5.26 | 5.88 | 6.15 | Upgrade
|
| Debt / FCF Ratio | - | 22.97 | 10.81 | 178.17 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.54 | 0.51 | 0.56 | 0.62 | 0.60 | 0.46 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.97 | 2.89 | 3.21 | 3.99 | 4.59 | 4.32 | Upgrade
|
| Net Debt / FCF Ratio | -109.59 | 16.71 | 7.80 | 135.08 | -6.66 | -3.27 | Upgrade
|
| Asset Turnover | 0.69 | 0.70 | 0.70 | 0.68 | 0.65 | 0.59 | Upgrade
|
| Inventory Turnover | 3.70 | 3.33 | 3.25 | 3.29 | 3.64 | 3.75 | Upgrade
|
| Quick Ratio | 0.77 | 0.84 | 0.61 | 0.47 | 0.41 | 0.49 | Upgrade
|
| Current Ratio | 1.20 | 1.35 | 1.04 | 0.85 | 0.79 | 0.80 | Upgrade
|
| Return on Equity (ROE) | 4.87% | 10.47% | 7.08% | 4.13% | 2.65% | 7.15% | Upgrade
|
| Return on Assets (ROA) | 2.32% | 2.21% | 1.90% | 1.47% | 1.19% | 0.97% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.22% | 4.99% | 4.36% | 3.31% | 2.18% | 2.21% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.90% | 5.20% | 5.00% | 4.20% | 3.30% | 2.70% | Upgrade
|
| Earnings Yield | 2.01% | 4.60% | 3.87% | 2.15% | 1.35% | 2.76% | Upgrade
|
| FCF Yield | -0.22% | 1.44% | 4.18% | 0.25% | -4.72% | -5.68% | Upgrade
|
| Dividend Yield | 1.49% | 1.40% | 1.29% | 0.71% | 0.70% | 0.62% | Upgrade
|
| Payout Ratio | 124.75% | 59.17% | 58.38% | 101.14% | 186.75% | 51.63% | Upgrade
|
| Buyback Yield / Dilution | -0.13% | -2.01% | 4.45% | -3.27% | 2.25% | -5.24% | Upgrade
|
| Total Shareholder Return | 1.36% | -0.61% | 5.74% | -2.55% | 2.95% | -4.63% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.